Forced Degradation Study: An Important Tool in Drug Development AB Roge, PS Tarte, MM Kumare, Dr. G R Shendarkar, Dr. S M Vadvalkar
Mangesh Kumare
View PDFchevron_right
Assessing mass balance in pharmaceutical drug products: New insights into an old topic
Steven Baertschi
TrAC Trends in Analytical Chemistry, 2013
View PDFchevron_right
The use of liquid chromatography±mass spectrometry for the identi®cation of drug degradation products in pharmaceutical formulations
Marco Garzotti
View PDFchevron_right
Review: Development of forced degradation studies of drugs
Scholar Science Journals
View PDFchevron_right
Forced Degradation Studies: Regulatory Considerations and Implementations in Analytical Method Development and Validation
Chetan Bhalgat
2018
View PDFchevron_right
An Introduction to Forced degradation studies for drug substances and drug products
MUSKAN singh
Journal of emerging technologies and innovative research, 2021
View PDFchevron_right
Author's Accepted Manuscript Development of forced degradation and stability indicating studies of drugs – A review
yang gattuso
View PDFchevron_right
Forced degradation studies for Drug Substances and Drug Products-Scientific and Regulatory Considerations
Kumar Sourabh Jain
View PDFchevron_right
Development of forced degradation and stability indicating studies of drugs—A review
Dr. Prajesh Prajapati
Journal of Pharmaceutical Analysis, 2014
View PDFchevron_right
Technical Considerations of Forced Degradation Studies of New Drug Substances and Product: Regulatory Perspectives
Parul Singh
Journal of Drug Delivery and Therapeutics, 2018
View PDFchevron_right
Current Trend in Performance of Forced Degradation Studies for Drug Substance and Drug Product’s
Rajveer Bhaskar
Journal of Drug Delivery and Therapeutics
View PDFchevron_right
Forced Degradation Studies: Practical Approach - Overview of Regulatory Guidance and Literature for the Drug Products and Drug Substances
kishore hotha
International Research Journal of Pharmacy, 2013
View PDFchevron_right
Strategies To Address Mutagenic Impurities Derived from Degradation in Drug Substances and Drug Products
Andrew Teasdale
Organic Process Research & Development, 2015
View PDFchevron_right
In situ degradation: a new concept for system suitability tests in monographs of the European Pharmacopoeia
Ulrich Rose
Journal of Pharmaceutical and Biomedical Analysis, 1998
View PDFchevron_right
Available guidance and best Practices for Conducting Forced degradation Studies Pharmaceutical Technology
Dan Reynolds
2002
View PDFchevron_right
Development and Validation of a Stability-indicating Method for Neostigmine Bromide: Separation, Identification and Characterization of Degradation Product using LC-MS and ESI-Q-TOF-MS/MS
parul grover
Indian Journal of Pharmaceutical Education and Research
View PDFchevron_right
Systematic strategies for degradation kinetic study of pharmaceuticals: an issue of utmost importance concerning current stability analysis practices
Tarang Jadav
Journal of Analytical Science and Technology, 2022
View PDFchevron_right
Exploration of Degradation Chemistry by Advanced Analytical Methodology
Anders Brunsvik
Energy Procedia, 2017
View PDFchevron_right
Strategy for identification and characterization of small quantities of drug degradation products using LC and LC-MS: Application to valsartan, a model drug
Saranjit Singh
Drug Testing and Analysis, 2010
View PDFchevron_right
Critical practical aspects in the application of liquid chromatography–mass spectrometric studies for the characterization of impurities and degradation products
Tarun Handa
Journal of Pharmaceutical and Biomedical Analysis, 2014
View PDFchevron_right
IDENTIFICATION, SEPARATION, AND CHARACTERIZATION OF DEGRADATION PRODUCTS OF TRIAMCINOLONE HEXACETONIDE USING LC AND LC-MS/MS
International Journal of Applied Pharmaceutics (IJAP), BHAVNA SUNIL MAHAJAN
International Journal of Applied Pharmaceutics, 2024
View PDFchevron_right
Identification of degradation products of saquinavir mesylate by ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry and its application to quality control
Dr Debasish Swain
Rapid Communications in Mass Spectrometry, 2017
View PDFchevron_right
Drug-Excipient Interactions: Case Studies and Overview of Drug Degradation Pathways
Swapan Roychowdhury, kishore hotha
View PDFchevron_right
Study of the forced degradation behavior of prasugrel hydrochloride by Liquid Chromatography with Mass spectrometry and liquid chromatography with NMR detection and prediction of the toxicity of the characterized degradation products
Tarun Handa
Journal of Separation Science, 2015
View PDFchevron_right
Identification of Degradation Products in Cyclophosphamide API by LC-QTOF Mass Spectrometry Identification of Degradation Products in Cyclophosphamide API by LC-QTOF Mass Spectrometry
shiva gudlawar
View PDFchevron_right
Identification and Characterization of Degradation Products of Lacosamide by Liquid-Chromatography/Time-Of-Flight Mass Spectrometric and Multi-Stage Mass Spectrometric Analysis
Ritesh Bhole
Journal of Liquid Chromatography & Related Technologies, 2014
View PDFchevron_right
Understanding and evaluation of different degradation pathways and stability of drug product with active substance prone to chemical and physical degradation
Packa Antovska
Macedonian Pharmaceutical Bulletin
View PDFchevron_right
A review article – development of forced degradation and stability indicating studies for drug substance and drug product
IJRPP Journal
View PDFchevron_right
Critical Reviews in Analytical Chemistry Development of impurity profiling methods using modern analytical techniques
Dr. Bondigalla Ramachandra
Critical Reviews in Analytical Chemistry, 2016
View PDFchevron_right
Analysis of drug impurities
Jorge Barradas
View PDFchevron_right
A NOVEL STABILITY-INDICATING RP-UPLC METHOD FOR THE QUANTIFICATION OF IMPURITIES AND A NEW QDa MASS DETECTOR COUPLED WITH LC-PDA FOR IDENTIFICATION OF MASS OF DEGRADATION PRODUCTS IN A FIXED DOSE COMBINATION OF EMPAGLIFLOZIN AND LANIGLIPTIN TABLETS USED AS SECOND-LINE THERAPY FOR TYPE-2 DIABETES
varaprasad jagadabi
International Research Journal of Pharmacy, 2018
View PDFchevron_right
IDENTIFICATION OF DABIGATRAN ETEXILATE MAJOR DEGRADATION PATHWAYS BY LIQUID CHROMATOGRAPHY COUPLED TO MULTI STAGE HIGH-RESOLUTION MASS SPECTROMETRY
caroline chodur
RSC Adv., 2015
View PDFchevron_right
Forced degradation of nepafenac: Development and validation of stability indicating UHPLC method
Irena Nekola
View PDFchevron_right
Liquid Chromatographic Peak Purity Assessments in Forced Degradation Studies: An Industry Perspective
Mariah Ultramari
Deleted Journal, 2024
View PDFchevron_right
Chromatographic separation of tiropramide hydrochloride and its degradation products along with their structural characterization using LC-QTOF-MS/MS and NMR
Bhoopendra Singh Kushwah
Research Square (Research Square), 2022
View PDFchevron_right